We are live on
!
Find out more
GA
GuoLine Advisory Portfolio holdings
AUM
$1.07B
1-Year Est. Return
26.27%
This Fund
S&P 500
This Quarter
Est. Return
+15.77%
1 Year Est. Return
+26.27%
3 Year Est. Return
+81.88%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$943M
AUM Growth
-$1.6M
(-0.17%)
Cap. Flow
-$103M
Cap. Flow
% of AUM
-10.98%
Top 10 Holdings %
Top 10 Hldgs %
65.69%
Holding
23
New
–
Increased
2
Reduced
3
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$14.4M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$6.14M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$38.6M |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$33M |
| 3 |
Visa
V
|
+$18.6M |
| 4 |
Mastercard
MA
|
+$18.6M |
| 5 |
S&P Global
SPGI
|
+$15.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 53.08% |
| 2 | Healthcare | 15.58% |
| 3 | Communication Services | 13.26% |
| 4 | Financials | 11.43% |
| 5 | Consumer Discretionary | 6.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$3.45T
| $120M | 12.71% |
240,900
| – | – |
|
2
Alphabet (Google) Class A
GOOGL
$4.36T
| $87.4M | 9.27% |
496,000
| – | – |
|
3
Apple
AAPL
$4.54T
| $76.3M | 8.09% |
371,700
| – | – |
|
4
Amazon
AMZN
$2.92T
| $62.7M | 6.65% |
285,680
| – | – |
|
5
Zscaler
ZS
$24.5B
| $60M | 6.36% |
191,060
| – | – |
|
6
ServiceNow
NOW
$115B
| $52.9M | 5.61% |
257,400
| – | – |
|
7
KLA
KLAC
$239B
| $47M | 4.99% |
525,000
| – | – |
|
|
8
Visa
V
$684B
| $37.9M | 4.02% |
106,700
-53,400
| -33% | -$18.6M |
|
|
9
Mastercard
MA
$502B
| $37.8M | 4.01% |
67,300
-33,600
| -33% | -$18.6M |
|
10
Meta Platforms (Facebook)
META
$1.42T
| $37.6M | 3.99% |
51,000
| – | – |
|
|
11
Regeneron Pharmaceuticals
REGN
$78.5B
| $35.3M | 3.75% |
67,300
+11,000
| +20% | +$6.14M |
|
|
12
TSMC
TSM
$2.1T
| $34.1M | 3.62% |
150,700
+77,700
| +106% | +$14.4M |
|
13
Salesforce
CRM
$151B
| $32.1M | 3.41% |
117,890
| – | – |
|
|
14
S&P Global
SPGI
$121B
| $32.1M | 3.41% |
60,900
-30,500
| -33% | -$15.2M |
|
15
Thermo Fisher Scientific
TMO
$213B
| $32M | 3.39% |
78,800
| – | – |
|
|
NVO
16
Novo Nordisk
NVO
$208B
| $29.5M | 3.12% |
426,700
| – | – |
|
17
Palo Alto Networks
PANW
$270B
| $27.7M | 2.93% |
135,200
| – | – |
|
18
CrowdStrike
CRWD
$194B
| $27.3M | 2.9% |
214,400
| – | – |
|
19
Zoetis
ZTS
$32.4B
| $27.2M | 2.88% |
174,400
| – | – |
|
20
Adobe
ADBE
$99.5B
| $23.2M | 2.46% |
60,020
| – | – |
|
21
GE HealthCare
GEHC
$30.7B
| $23M | 2.44% |
310,700
| – | – |
|
|
22
Arthur J. Gallagher & Co
AJG
$64.1B
| – | – |
-95,500
| Closed | -$33M |
|
|
23
Vertex Pharmaceuticals
VRTX
$121B
| – | – |
-79,700
| Closed | -$38.6M |
|
Similar funds
SCM
PP
DCP
ZIG
EC
FNT
TAM
EG
GuoLine Advisory's Q2 2025 Portfolio in Review
As of Q2 2025, GuoLine Advisory held 23 positions worth $943M, down 0.17% from $945M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
GuoLine Advisory withdrew a net $103M in Q2 2025, closing 2 positions and reducing 3 holdings. Its most notable exit was Vertex Pharmaceuticals, an estimated $38.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 53% of assets, up from 42% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, GuoLine Advisory added an estimated $14.4M to TSMC.
- GuoLine Advisory added most to TSMC in Q2 2025, an estimated $14.4M increase.
- GuoLine Advisory's biggest Q2 2025 reduction was Visa, cutting an estimated $18.6M.
- GuoLine Advisory fully exited Vertex Pharmaceuticals in Q2 2025, selling an estimated $38.6M.
- GuoLine Advisory's ten largest holdings make up 66% of its $943M portfolio in Q2 2025.
- GuoLine Advisory opened 0 new positions and closed 2 in Q2 2025.
- GuoLine Advisory's portfolio value fell 0.17% quarter-over-quarter to $943M.
Based on GuoLine Advisory's 13F filing for Q2 2025, filed 7 Jul 2025.